Tinzaparin sodium (Innohep®)

All Wales Medicines Strategy Group (AWMSG)
Record ID 32015001229
Authors' recommendations: Tinzaparin sodium (innohep® Syringe) is recommended as an option for use within NHS Wales for the extended treatment of symptomatic venous thromboembolism and prevention of its recurrence in adult patients with solid tumours.
Project Status: Completed
Year Published: 2015
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Wales, United Kingdom
MeSH Terms
  • Humans
  • Venous Thromboembolism
  • Heparin, Low-Molecular-Weight
  • Adult
  • Neoplasms
  • Recurrence
Organisation Name: All Wales Medicines Strategy Group
Contact Address: All Wales Therapeutics and Toxicology Centre, Academic Centre, University Hospital Llandough, Penlan Road, Penarth, Vale of Glamorgan CF64 2XX
Contact Name: AWTTC@wales.nhs.uk
Contact Email: AWTTC@wales.nhs.uk
Copyright: AWTTC
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.